AUS
NZ
UK
CA
USA
IND
Highlights
- Stock has received target price upgrades from multiple analysts in recent months.
- Institutional investors hold 78.63% of the company's stock.
- Strong quarterly earnings and revenue growth reported, surpassing analysts’ expectations.
Philip Morris International Inc., a major player in the consumer sector, continues to attract attention with its solid market performance and positive analyst ratings. As part of the NYSE Consumer Stocks, the company has seen significant upgrades in price targets and enjoys strong institutional support. This blog highlights the latest developments and performance metrics for Philip Morris.
Philip Morris International Inc. (NYSE:PM) Receives Positive Analyst Ratings and Price Target Adjustments
Philip Morris International Inc. continues to garner positive attention from analysts, maintaining a "Moderate Buy" consensus rating. With a solid base of buy ratings and only a few hold and sell recommendations, the stock demonstrates strong market sentiment. The average 12-month price target for Philip Morris shares is set at $131.50, reflecting optimism for the company’s growth prospects.
Analyst Upgrades and Price Target Increases
In recent weeks, several leading research firms have adjusted their price targets for Philip Morris. Barclays raised its target price from $145.00 to $155.00, citing the company’s strong growth potential. JPMorgan Chase & Co. also raised its price target to $145.00, maintaining an "overweight" rating. Other institutions, such as Citigroup and Deutsche Bank, followed suit with price target hikes, signaling heightened confidence in Philip Morris' future performance and prospects.
Institutional Investor Confidence
Institutional investors continue to show significant confidence in Philip Morris. Currently, 78.63% of the company’s stock is held by hedge funds and other large financial institutions. Notably, recent data reveals that major investors such as Valley Wealth Managers and Dunhill Financial have increased their holdings, further reinforcing the company’s stability. This institutional support indicates continued confidence in the company’s long-term growth potential.
Stock Performance and Key Market Metrics
Philip Morris shares recently opened at $130.99, reflecting the stock’s solid market position. With a market capitalization of $203.67 billion, the company remains a significant player in the market. The stock’s price-to-earnings (P/E) ratio stands at 20.79, with a price-to-earnings-to-growth (P/E/G) ratio of 2.33, indicating fair valuation relative to growth expectations. Over the past year, Philip Morris’ stock has fluctuated between a low of $87.82 and a high of $134.15, showing stability and steady performance. The 50-day moving average of $125.74 and 200-day moving average of $115.99 further highlight the company’s consistent upward momentum.
Strong Quarterly Earnings Performance
Philip Morris exceeded analysts’ expectations in its latest earnings report for the third quarter. The company posted earnings per share (EPS) of $1.91, surpassing the consensus estimate of $1.82. Revenue for the quarter reached $9.91 billion, representing an 8.4% increase compared to the same period last year. This positive performance underscores Philip Morris’ ability to navigate market challenges and deliver strong financial results.
Dividend Increase Demonstrates Financial Strength
Philip Morris recently raised its quarterly dividend from $1.30 to $1.35 per share. With an annual dividend of $5.40 and a dividend yield of 4.12%, this increase highlights the company’s financial health and commitment to returning value to shareholders. The dividend payout ratio stands at 85.71%, signaling strong cash flow generation.
Company’s Focus on Smoke-Free Products
Philip Morris International is a global tobacco company that is shifting its focus towards a smoke-free future. Its portfolio includes traditional cigarettes as well as innovative smoke-free products, including heat-not-burn, vapor, and oral nicotine products. Popular brands such as IQOS and ZYN are part of the company’s strategy to reduce smoking-related harm while diversifying its product offerings.
